Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Neurocrine Biosciences Total Assets 2010-2024 | NBIX

Neurocrine Biosciences total assets from 2010 to 2024. Total assets can be defined as the sum of all assets on a company's balance sheet.
  • Neurocrine Biosciences total assets for the quarter ending September 30, 2024 were $3.535B, a 24.11% increase year-over-year.
  • Neurocrine Biosciences total assets for 2023 were $3.251B, a 37.27% increase from 2022.
  • Neurocrine Biosciences total assets for 2022 were $2.369B, a 14.29% increase from 2021.
  • Neurocrine Biosciences total assets for 2021 were $2.073B, a 19.47% increase from 2020.
  
Neurocrine Biosciences Annual Total Assets
(Millions of US $)
2023 $3,251
2022 $2,369
2021 $2,073
2020 $1,735
2019 $1,306
2018 $993
2017 $818
2016 $365
2015 $475
2014 $243
2013 $155
2012 $196
2011 $138
2010 $144
2009 $71
Neurocrine Biosciences Quarterly Total Assets
(Millions of US $)
2024-09-30 $3,535
2024-06-30 $3,305
2024-03-31 $3,472
2023-12-31 $3,251
2023-09-30 $2,848
2023-06-30 $2,613
2023-03-31 $2,360
2022-12-31 $2,369
2022-09-30 $2,143
2022-06-30 $2,006
2022-03-31 $2,145
2021-12-31 $2,073
2021-09-30 $2,017
2021-06-30 $1,956
2021-03-31 $1,846
2020-12-31 $1,735
2020-09-30 $1,503
2020-06-30 $1,516
2020-03-31 $1,362
2019-12-31 $1,306
2019-09-30 $1,180
2019-06-30 $1,067
2019-03-31 $958
2018-12-31 $993
2018-09-30 $934
2018-06-30 $841
2018-03-31 $806
2017-12-31 $818
2017-09-30 $772
2017-06-30 $754
2017-03-31 $289
2016-12-31 $365
2016-09-30 $399
2016-06-30 $430
2016-03-31 $459
2015-12-31 $475
2015-09-30 $492
2015-06-30 $511
2015-03-31 $528
2014-12-31 $243
2014-09-30 $258
2014-06-30 $270
2014-03-31 $279
2013-12-31 $155
2013-09-30 $166
2013-06-30 $175
2013-03-31 $184
2012-12-31 $196
2012-09-30 $193
2012-06-30 $202
2012-03-31 $210
2011-12-31 $138
2011-09-30 $149
2011-06-30 $127
2011-03-31 $134
2010-12-31 $144
2010-09-30 $150
2010-06-30 $155
2010-03-31 $80
2009-12-31 $71
2009-09-30 $76
2009-06-30 $87
2009-03-31 $101
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $11.890B $1.887B
Neurocrine Biosciences is a neuroscience-based company focused on the discovery and development of novel therapeutics for neuropsychiatric, neuroinflammatory and neurodegenerative diseases and disorders. The company's neuroscience, endocrine and immunology disciplines provide a unique biological understanding of the molecular interaction between central nervous, immune and endocrine systems for the development of therapeutic interventions for anxiety, depression, insomnia, stroke, malignant brain tumors, multiple sclerosis, obesity and diabetes.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $79.017B 30.41
Takeda Pharmaceutical (TAK) Japan $43.337B 9.02
Sandoz Group AG (SDZNY) Switzerland $19.524B 0.00
Merck (MKKGY) Germany $19.470B 17.44
Astellas Pharma (ALPMY) Japan $19.363B 17.83
United Therapeutics (UTHR) United States $16.217B 15.95
Summit Therapeutics (SMMT) United States $13.503B 0.00
Shionogi (SGIOY) Japan $12.119B 11.61
Catalent (CTLT) United States $10.727B 0.00
Jazz Pharmaceuticals (JAZZ) Ireland $7.354B 7.19
Orion OYJ (ORINY) Finland $6.653B 18.71
Madrigal Pharmaceuticals (MDGL) United States $6.294B 0.00
Corcept Therapeutics (CORT) United States $5.431B 41.13
Ionis Pharmaceuticals (IONS) United States $5.422B 0.00
Crinetics Pharmaceuticals (CRNX) United States $5.075B 0.00
PTC Therapeutics (PTCT) United States $3.026B 0.00
Dyne Therapeutics (DYN) United States $2.889B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $2.622B 15.69
Catalyst Pharmaceuticals (CPRX) United States $2.457B 11.14
Arrowhead Pharmaceuticals (ARWR) United States $2.309B 0.00
NewAmsterdam Pharma (NAMS) Netherlands $2.300B 0.00
Soleno Therapeutics (SLNO) United States $2.233B 0.00
Evotec AG (EVO) Germany $1.928B 0.00
Centessa Pharmaceuticals (CNTA) United Kingdom $1.813B 0.00
Recursion Pharmaceuticals (RXRX) United States $1.770B 0.00
Xencor (XNCR) United States $1.614B 0.00
BioCryst Pharmaceuticals (BCRX) United States $1.456B 0.00
Ocular Therapeutix (OCUL) United States $1.440B 0.00
Harrow (HROW) United States $1.389B 0.00
ARS Pharmaceuticals (SPRY) United States $1.362B 0.00
Indivior (INDV) United States $1.354B 5.52
Guardian Pharmacy Services (GRDN) United States $1.300B 0.00
Cassava Sciences (SAVA) United States $1.295B 0.00
Enliven Therapeutics (ELVN) United States $1.193B 0.00
Ardelyx (ARDX) United States $1.177B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.163B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $1.050B 0.00
Collegium Pharmaceutical (COLL) United States $0.954B 5.21
Bioventus (BVS) United States $0.912B 28.82
Relay Therapeutics (RLAY) United States $0.854B 0.00
USANA Health Sciences (USNA) United States $0.769B 14.25
Cronos Group (CRON) Canada $0.768B 0.00
Ironwood Pharmaceuticals (IRWD) United States $0.674B 0.00
Tourmaline Bio (TRML) United States $0.650B 0.00
Exscientia (EXAI) United Kingdom $0.613B 0.00
Elite Pharmaceuticals (ELTP) United States $0.600B 0.00
Altimmune (ALT) United States $0.541B 0.00
Organogenesis (ORGO) United States $0.512B 0.00
Savara (SVRA) United States $0.511B 0.00
ProKidney (PROK) United States $0.491B 0.00
Theravance Biopharma (TBPH) Cayman Islands $0.468B 0.00
Zevra Therapeutics (ZVRA) United States $0.460B 0.00
OmniAb (OABI) United States $0.458B 0.00
Korro Bio (KRRO) United States $0.446B 0.00
Xeris Biopharma Holdings (XERS) United States $0.435B 0.00
Larimar Therapeutics (LRMR) United States $0.427B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.425B 172.14
Siga Technologies (SIGA) United States $0.424B 4.95
Esperion Therapeutics (ESPR) United States $0.418B 0.00
KalVista Pharmaceuticals (KALV) United States $0.410B 0.00
4D Molecular Therapeutics (FDMT) United States $0.408B 0.00
Verve Therapeutics (VERV) United States $0.406B 0.00
Aquestive Therapeutics (AQST) United States $0.405B 0.00
Akebia Therapeutics (AKBA) United States $0.391B 0.00
Silence Therapeutics (SLN) United Kingdom $0.380B 0.00
Amylyx Pharmaceuticals (AMLX) United States $0.326B 0.00
Avita Medical (RCEL) United States $0.313B 0.00
Sage Therapeutics (SAGE) United States $0.312B 0.00
Lyell Immunopharma (LYEL) United States $0.307B 0.00
Nature's Sunshine Products (NATR) United States $0.296B 17.58
Aldeyra Therapeutics (ALDX) United States $0.251B 0.00
Pyxis Oncology (PYXS) United States $0.249B 0.00
Lexeo Therapeutics (LXEO) United States $0.220B 0.00
Acrivon Therapeutics (ACRV) United States $0.217B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.202B 0.00
Enanta Pharmaceuticals (ENTA) United States $0.202B 0.00
Profound Medical (PROF) Canada $0.198B 0.00
Nektar Therapeutics (NKTR) United States $0.197B 0.00
Nanobiotix S.A (NBTX) France $0.185B 0.00
Heron Therapeutics (HRTX) United States $0.181B 0.00
Galectin Therapeutics (GALT) United States $0.174B 0.00
MediWound (MDWD) Israel $0.173B 0.00
Cardiol Therapeutics (CRDL) Canada $0.149B 0.00
CytoDyn (CYDY) United States $0.148B 0.00
Aclaris Therapeutics (ACRS) United States $0.146B 0.00
Achieve Life Sciences (ACHV) Canada $0.146B 0.00
Context Therapeutics (CNTX) United States $0.138B 0.00
Avalo Therapeutics (AVTX) United States $0.129B 0.00
Incannex Healthcare (IXHL) Australia $0.127B 0.00
Telomir Pharmaceuticals (TELO) United States $0.110B 0.00
Journey Medical (DERM) United States $0.107B 0.00
Century Therapeutics (IPSC) United States $0.104B 0.00
VAXART, INC (VXRT) United States $0.103B 0.00
Innate Pharma SA (IPHYF) France $0.103B 0.00
Karyopharm Therapeutics (KPTI) United States $0.102B 0.00
Fractyl Health (GUTS) United States $0.095B 0.00
Regulus Therapeutics (RGLS) United States $0.094B 0.00
Arch Biopartners (ACHFF) Canada $0.092B 0.00
Relmada Therapeutics (RLMD) United States $0.091B 0.00
PMV Pharmaceuticals (PMVP) United States $0.083B 0.00
CASI Pharmaceuticals (CASI) China $0.082B 0.00
Vivani Medical (VANI) United States $0.078B 0.00
Assertio Holdings (ASRT) United States $0.077B 20.28
ESSA Pharma (EPIX) Canada $0.076B 0.00
Swiftmerge Acquisition (IVCP) United States $0.076B 0.00
ElectroCore (ECOR) United States $0.072B 0.00
Inotiv (NOTV) United States $0.070B 0.00
Scienture Holdings (SCNX) United States $0.069B 0.00
Metagenomi (MGX) United States $0.068B 0.00
AlloVir (ALVR) United States $0.066B 0.00
OptiNose (OPTN) United States $0.066B 0.00
Champions Oncology (CSBR) United States $0.061B 0.00
Mural Oncology (MURA) Ireland $0.059B 0.00
Prelude Therapeutics (PRLD) United States $0.057B 0.00
Nutriband (NTRB) United States $0.053B 0.00
Protara Therapeutics (TARA) United States $0.051B 0.00
Gain Therapeutics (GANX) United States $0.049B 0.00
Unicycive Therapeutics (UNCY) United States $0.048B 0.00
SCYNEXIS (SCYX) United States $0.046B 0.00
Rafael Holdings (RFL) United States $0.045B 0.00
VYNE Therapeutics (VYNE) United States $0.040B 0.00
BioLineRx (BLRX) Israel $0.038B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.038B 0.00
Iterum Therapeutics (ITRM) Ireland $0.038B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.038B 0.00
Carisma Therapeutics (CARM) United States $0.037B 0.00
Citius Pharmaceuticals (CTXR) United States $0.036B 0.00
FibroGen (FGEN) United States $0.034B 0.00
DURECT (DRRX) United States $0.031B 0.00
BioVie (BIVI) United States $0.030B 0.00
Surrozen (SRZN) United States $0.029B 0.00
Oruka Therapeutics (ORKA) United States $0.029B 0.00
Natural Alternatives (NAII) United States $0.028B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.027B 0.00
GlycoMimetics (GLYC) United States $0.027B 0.00
Lipocine (LPCN) United States $0.026B 0.00
Enlivex Therapeutics (ENLV) Israel $0.023B 0.00
Tempest Therapeutics (TPST) United States $0.022B 0.00
MEI Pharma (MEIP) United States $0.019B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.018B 0.00
ProPhase Labs (PRPH) United States $0.018B 0.00
PolyPid (PYPD) Israel $0.017B 0.00
Marinus Pharmaceuticals (MRNS) United States $0.017B 0.00
TherapeuticsMD (TXMD) United States $0.016B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.016B 0.00
Mannatech (MTEX) United States $0.016B 0.00
Minerva Neurosciences (NERV) United States $0.015B 0.00
Inhibikase Therapeutics (IKT) United States $0.015B 0.00
Cosmos Health (COSM) United States $0.015B 0.00
NRx Pharmaceuticals (NRXP) United States $0.014B 0.00
Vivos Therapeutics (VVOS) United States $0.014B 0.00
Nuvilex (PMCB) United States $0.013B 0.00
NLS Pharmaceutics (NLSP) Switzerland $0.012B 0.00
Talphera (TLPH) United States $0.012B 0.00
Indaptus Therapeutics (INDP) United States $0.011B 0.00
Lyra Therapeutics (LYRA) United States $0.011B 0.00
Dominari Holdings (DOMH) United States $0.011B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.010B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.010B 0.00
Redhill Biopharma (RDHL) Israel $0.009B 0.00
Traws Pharma (TRAW) United States $0.009B 0.00
Jaguar Animal Health (JAGX) United States $0.009B 0.00
Addex Therapeutics (ADXN) Switzerland $0.009B 0.00
Conduit Pharmaceuticals (CDT) United States $0.008B 0.00
Plus Therapeutics (PSTV) United States $0.007B 0.00
Ainos (AIMD) United States $0.006B 0.00
Viracta Therapeutics (VIRX) United States $0.006B 0.00
Biomerica (BMRA) United States $0.006B 0.00
TransCode Therapeutics (RNAZ) United States $0.006B 0.00
Mangoceuticals (MGRX) United States $0.006B 0.00
Klotho Neurosciences (KLTO) United States $0.006B 0.00
Xenetic Biosciences (XBIO) United States $0.006B 0.00
SHINECO (SISI) China $0.004B 0.00
Avenue Therapeutics (ATXI) United States $0.004B 0.11
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.004B 0.00
Aptorum Group (APM) United Kingdom $0.004B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.003B 0.00
Oncternal Therapeutics (ONCT) United States $0.003B 0.00
Alaunos Therapeutics (TCRT) United States $0.003B 0.00
Heatwurx (PCSA) United States $0.003B 0.00
TNF Pharmaceuticals (TNFA) United States $0.003B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.003B 0.00
Molecular Templates (MTEM) United States $0.003B 0.00
InMed Pharmaceuticals (INM) Canada $0.003B 0.00
Petros Pharmaceuticals (PTPI) United States $0.003B 0.00
XORTX Therapeutics (XRTX) Canada $0.003B 0.00
SciSparc (SPRC) Israel $0.002B 0.00
Phio Pharmaceuticals (PHIO) United States $0.002B 0.00
Clearmind Medicine (CMND) Canada $0.002B 0.00
Bio-Path Holdings (BPTH) United States $0.002B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.002B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.002B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.002B 0.00
China SXT Pharmaceuticals (SXTC) China $0.002B 0.00
Altamira Therapeutics (CYTO) Bermuda $0.002B 0.00
Aditxt (ADTX) United States $0.001B 0.00
Qualigen Therapeutics (QLGN) United States $0.001B 0.00
Universe Pharmaceuticals INC (UPC) China $0.001B 0.00
PainReform (PRFX) Israel $0.000B 0.00
CERo Therapeutics Holdings (CERO) United States $0.000B 0.00
Grifols, S.A (GRFS) Spain $0.000B 0.00
4D Pharma (LBPS) United Kingdom $0.000B 0.00
Procaps Group, S.A (PROC) Luxembourg $0.000B 1.33
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00
Stevanato Group S.p.A (STVN) Italy $0.000B 37.26